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a b s t r a c t
Neural precursor cell expressed, developmentally down-regulated protein 4-2 (Nedd4-2) mediates the
internalisation / degradation of epithelial Naþ channel subunits (α-, β- and γ-ENaC). Serum /
glucocorticoid inducible kinase 1 (SGK1) and protein kinase A (PKA) both appear to inhibit this process
by phosphorylating Nedd4-2-Ser221, -Ser327 and -Thr246. This Nedd4-2 inactivation process is thought to
be central to the hormonal control of Naþ absorption. The present study of H441 human airway
epithelial cells therefore explores the effects of SGK1 and / or PKA upon the phosphorylation /
abundance of endogenous Nedd4-2; the surface expression of ENaC subunits, and electrogenic Naþ
transport. Effects on Nedd4-2 phosphorylation/abundance and the surface expression of ENaC were
monitored by western analysis, whilst Naþ absorption was quantiﬁed electrometrically. Acutely (20 min)
activating PKA in glucocorticoid-deprived (24 h) cells increased the abundance of Ser221-phosphorylated,
Ser327-phosphorylated and total Nedd4-2 without altering the abundance of Thr246-phosphorylated
Nedd4-2. Activating PKA under these conditions did not cause a co-ordinated increase in the surface
abundance of α-, β- and γ-ENaC and had only a very small effect upon electrogenic Naþ absorption.
Activating PKA (20 min) in glucocorticoid-treated (0.2 mM dexamethasone, 24 h) cells, on the other hand,
increased the abundance of Ser221-, Ser327- and Thr246-phosphorylated and total Nedd4-2; increased the
surface abundance of α-, β- and γ-ENaC and evoked a clear stimulation of Naþ transport. Chronic
glucocorticoid stimulation therefore appears to allow cAMP-dependent control of Naþ absorption by
facilitating the effects of PKA upon the Nedd4-2 and ENaC subunits.
& 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/3.0/).
1. Introduction
The controlled absorption of Naþ from the liquid ﬁlm covering
the lung / airway epithelia is vital to the integrated functioning of
the respiratory tract and occurs via a ‘leak-pump0 mechanism in
which the overall rate of Naþ absorption is limited by the rate of
apical Naþ entry though epithelial Naþ channels (ENaC). Gluco-
corticoids are clearly important to the induction and maintenance
of this Naþ absorbing phenotype and synthetic glucocorticoids are
therefore used in the clinical management of conditions, such as
respiratory distress and pulmonary oedema, that involve dysfunc-
tion of pulmonary Naþ absorption (Barker and Olver, 2002;
Boucher, 2004; 2007; Matthay et al., 2002; Olver et al., 2004;
Wilson et al., 2007). However, despite their clear importance, the
mechanisms that allow these hormones to control pulmonary Naþ
transport are not understood fully (Barnes, 2011; Matthay et al.,
2002; Olver et al., 2004).
Epithelial Naþ channels are composed of three subunits (α-,
β- and γ-ENaC) that contain proline-rich domains which provide
binding sites for neural precursor cell expressed, developmentally
down-regulated protein 4-2 (Nedd4-2). The binding of Nedd4-2 to
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these sites targets the ENaC channel complex for internalisation
and degradation and, in unstimulated cells, this internalisation/
degradation process is thought to limit the surface abundance of
ENaC and thus restrict the rate of Naþ transport (Debonneville et
al., 2001; Snyder et al., 2004a; Snyder et al., 2002). Nedd4-2 gene
deletion thus disrupts lung function by inducing excessive Naþ
absorption that reﬂects an increase in the amount of α-, β- and
γ-ENaC at the cell surface (Boase et al., 2011; Kimura et al., 2011).
However, it is also clear that Nedd4-2 can be phosphorylated at
Ser221, Ser327 and Thr246 by serum / glucocorticoid-inducible
kinase 1 (SGK1) and by protein kinase A (PKA). Since this
phosphorylation of Nedd4-2 blocks the interaction with ENaC,
it is thought to cause an increase in the amount or α-, β- and
γ-ENaC present at the cell surface. Moreover, since SGK1 and PKA
are under hormonal control, the regulated phosphorylation /
inactivation of Nedd4-2 is thought to allow control over the rate
of Naþ absorption (Baines, 2013; Boase et al., 2011; Debonneville
et al., 2001; Flores et al., 2003, 2005; Kimura et al., 2011; Morris
and Schafer, 2002; Snyder et al., 2002, 2004a, 2004b; ). However,
few authors have quantiﬁed the phosphorylation of endogenous
Nedd4-2 (see Flores et al., 2005) and the evidence supporting this
model is mainly derived from heterologous expression systems
(Chandran et al., 2011; Debonneville et al., 2001; Snyder et al.,
2002, 2004a). To clarify the mechanisms that allow hormones to
regulate pulmonary Naþ transport, we now use newly-developed,
phospho-peptide speciﬁc antibodies to study the effects of SGK1
and PKA upon the phosphorylation of endogenous Nedd4-2 in a
Naþ absorbing human airway epithelial cells (H441) (Althaus et
al., 2010; Clunes et al., 2004; Lazrak and Matalon, 2003; Thomas et
al., 2004; Watt et al., 2012).
2. Materials and methods
2.1. Antibodies
The polyclonal antibodies against Nedd4-2 were all produced
within the MRC Protein Phosphorylation Unit (MRC-PPU), College
of Life Sciences, University of Dundee and were generously made
available by Professor Sir Philip Cohen and Professor Carol MacK-
intosh. The antibody against Ser221- (antibody identiﬁcation num-
ber: DSTT-S754A) phosphorylated Nedd4-2 was generated against
a phospho-peptide (SRLRSCSnVTDTVA, where n indicates phos-
phorylated residue) corresponding to the residues 215–227 of
human Nedd4-2. Similarly, the antibodies against the Ser327-
(DSTT-S755A) and Thr246-phosphorylated (DSTT-S753A) Nedd4-2
were directed against residues 317–331 (CEPQIRPRSLSnSPTV) and
240–252 (GRARSSTnVTGGEE) respectively. Initial studies under-
taken by Dr James Hastie (Antibody production unit, MRC Protein
Phosphorylation Unit, University of Dundee) conﬁrmed that these
phospho-peptide speciﬁc antibodies displayed minimal afﬁnity for
unphosphorylated, GST-Nedd4-2 but did bind to GST-Nedd4-2 that
had been phosphorylated in vitro using recombinant protein
kinase B or SGK1. The antibodies therefore recognise the Ser221-,
Ser327 and Thr246-phosphorylated forms of human Nedd4-2. The
antibody against total Nedd4-2 (DSTT-S741B) was raised in sheep
against recombinant His-tagged Nedd4-2 expressed in insect cells.
Antibodies against total (DSTT-S276B) and Thr346/356/366-phos-
phorylated (DSTT-S231B) forms of the protein encoded by N-
myc-downstream regulated gene 1 (NDRG1) were also from the
MRC-PPU (Murray et al., 2004) whilst the antibodies against the
total and Ser133-phosphorylated cyclic AMP response element
binding protein (CREB) were from Cell Signalling (Hertfordhire,
UK). The antibody against α-ENaC was a gift from Prof. Rick
Boucher (Cystic Fibrosis Center, University of North Carolina,
USA), whilst the β-ENaC was from Santa Cruz Biotechnology
(Heidelberg, Germany; product code SC-21013) and the γ-ENaC
antibody from Sigma (Poole, Dorset UK; product code E4902).
2.2. Cell culture
Stocks of H441 human airway epithelial cells were maintained
in RPMI medium supplemented with 8.5% foetal bovine serum,
8.5% newborn calf serum (Life Technologies Ltd, Paisley, UK),
2 mM glutamine, 5 mg ml1 transferrin, 5 ng ml1 selenium and
an antibiotic / antimycotic mixture (Sigma Chemical Co., Poole,
Dorset). For experiments, cells removed from culture ﬂasks using
trypsin/ethylene diamine tetra acetic acid (EDTA) were plated onto
6 well plates (analysis of extracted protein) or Costar “Snapwell”
membranes (electrometric experiments) and maintained in this
standard growth medium for 5–7 days. Twenty four hours before
being used in experiments, this mediumwas replaced with a fully-
deﬁned medium identical to that described above except that (i) it
contained 20 nM insulin and (ii) the serum components were
replaced with FBS (8.5%) that had been dialysed (molecular weight
cuto10 KDa) to remove hormones/growth factors (Life technolo-
gies, ltd., product code 26400044). “Glucocorticoid-deprived” cells
were maintained in this nominally hormone-free medium for 24 h
before being used in experiments whilst “dexamethasone-treated”
cells were maintained in medium supplemented with 0.2 mM dex-
amethasone for 3 h (brief exposure) or 24 h (chronic exposure). In
some experiments cells were exposed to a cocktail of compounds
(10 mM forskolin, 100 mM iso-butylmethylxanthine and 1mM N-6-2-
O-dibutyryladenosine 3050-cyclic monophosphosphate, referred to as
cAMP agonists) that activate cAMP-dependent signalling pathways.
2.3. Expression/phosphorylation of Nedd4-2
Control/stimulated cells were washed with ice-cold phosphate
buffered saline and scraped into ice-cold lysis buffer containing
protease and phosphatase inhibitors (1% Triton; 50 mM Tris–HCl,
pH 7.5; 1 mM EGTA; 1 mM EDTA; 1 mM Na orthovanadate; 10 mM
glycerol phosphate; 50 mM NaF; 5 mM Na pyrophosphate;
270 mM sucrose; 0.1% β-mercaptoethanol; 1 Roche Mini Protease
Inhibitor tablet per 10 ml). The lysates were then ultrasonicated
and their protein contents determined using Bradford reagent.
Aliquots (1 mg) of extracted protein were then cleared by incuba-
tion (1 h, 4 1C) with uncoated Sepharose G beads and the cleared
lysates then exposed to Sepharose G beads coated with 10 mg of
anti Nedd4-2. After 1 h incubation at 4 1C with continual agitation,
the beads were precipitated by centrifugation; washed sequen-
tially with high (500 mM NaCl, 50 mM Tris / HCl; pH 7.5) and low
(50 mM NaCl, 1 mM EDTA, 0.1% β-mercaptoethanol; Tris / HCl, pH
7.5) salt buffers, and adherent proteins recovered by heating the
beads to 95 1C in the sample buffer used for sodium dodecyl
sulphate-polyacylamide gel electrophoresis (SDS-PAGE). Proteins
puriﬁed in this way were fractionated by SDS-PAGE and trans-
ferred to Hybond-P membranes (Amersham, Bucks., UK) that were
probed using antibodies against Ser221-, Ser327- or Thr246-phos-
phorylated Nedd4-2. Blots were then stripped and re-probed using
antibodies against the full length protein. This method allowed the
recovery of two proteins with molecular weights (105 kDa and
125 kDa) consistent with Nedd4-2 expression (Boase et al., 2011),
and initial experiments conﬁrmed that the recovery of these
proteins was dependent upon the inclusion of anti Nedd4-2 in
the immunoprecipitation reaction.
2.4. Surface expression of ENaC subunits
Control/stimulated cells were exposed (1 hour at 4 1C with
gentle agitation) to 10 mM sulfosuccinimidyl-2-(biotinamido)-
ethyl-1,30dithioproprionate (EZ-Link Sulfo-NHS-SS-Biotin, Pierce,
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Fischer Scientiﬁc, UK) to attach a cleavable biotin moiety to
surface-exposed proteins. The biotinylation reaction was then
terminated (100 mM ice cold glycine), the cells lysed and aliquots
(0.5 mg) of extracted protein incubated (1 h at room temperature)
with streptavidin-coated agarose beads in order to isolate the
biotinylated, surface proteins. These beads were then washed and
biotinylated proteins recovered by heating in SDS-PAGE sample
buffer. Changes to the surface abundance of α-, β- and γ-ENaC
were monitored by subjecting the biotinylated proteins to Western
analysis using antibodies against these channel subunits. A full
account of this method, which allows surface-exposed proteins to
be isolated with 95% purity, is presented elsewhere (Watt et al.,
2012).
2.5. Assay of SGK1/PKA activity
Aliquots (40 mg) of protein from control / stimulated cells were
fractionated by SDS-PAGE and subject to Western analysis using
antibodies against the Thr346/356/366-phosphorylated and total
NDRG1, and Ser133-phosphorylated and total CREB. NDRG1-
Thr346/356/366 is phosphorylated by SGK1 but not by other, closely
related kinases, and increased phosphorylation of these residues
must therefore reﬂect an increase in the activity of this kinase
(Inglis et al., 2009; Murray et al., 2004, 2005). Similarly, increased
phosphorylation of CREB-Ser133 was assumed to reﬂect increased
PKA activity since this residue is an archetypical PKA substrate.
2.6. Transepithelial Naþ transport
Cells grown to conﬂuence on Snapwell membrane were mounted
in Ussing chambers where the current required to hold the transe-
pithelial voltage at 0 mV was monitored as an indicator of active ion
transport (Ussing, 1960). In all such experiments, the apical and
basolateral sides of the cultured epithelial layers were each bathed
with 15 ml of bicarbonate buffered Ringer solution (composition in
mM: NaCl, 112; NaHCO3, 25; KCl, 4.7; MgSO4, 1.2; KH2PO4, 1.2; CaCl2,
2.5 and D-glucose, 11.6, pH 7.3–7.5 when bubbled with 5% CO2) which
was continually circulated by bubbling with 5% CO2/95% O2. The
current generated by control / stimulated cells was monitored for
30 min before amiloride (10 mM)was added to the apical bath in order
to block ENaC. The amiloride-sensitive component of the transepithe-
lial current (IAmil) was quantiﬁed as an indicator of electrogenic Naþ
absorption.
2.7. Data analysis/experimental design
Control / experimental cells were derived from the same
culture ﬂasks and subject to an identical series of solution changes.
Control cells were always exposed to solvent vehicle and proteins
from control/experimental cells were extracted and processed in
parallel using identical reagents. None of the effects reported here
can thus be attributed to non-speciﬁc actions (e.g. exposure to
solvent vehicle). For quantitative analysis, a computer scanner was
used to produce image ﬁles of each blot, and a standard software
package (ImageJ) then used to quantify the optical density of the
bands corresponding to control/experimental protein. Background
subtraction was achieved by subtracting the optical density of an
identically sized area of clear gel immediately adjacent to the
region of interest. To present the pooled data from a series of
experiments, individual data values were normalised to the mean
density derived by analysis of all control samples within a
particular experimental group (i.e. the value derived from the
entire series of experiments), and data are therefore shown as fold
change over control. Minor adjustments were made to the contrast
/ brightness of presented images but these changes were applied
to the entire image and did not enhance, obscure, move or
introduce any feature. Cited molecular weights were estimated
by reference to a series of protein standards. The results of
experiments that explored the effects of a single test substance
were analysed using Student's t-test, whilst the data from experi-
ments that followed more complex protocols were analysed by
one way analysis of variance (ANOVA) / Bonferroni post hoc test.
Data are shown as mean7S.E.M, and values of n denote the
number of independent experiments.
3. Results
3.1. Effects of dexamethasone/cAMP agonists on SGK1 and PKA
Brief (3 h) exposure to dexamethasone (0.2 mM) increased the
abundance of Thr346/356/366-phosphorylated NDRG1 but did not
alter the overall NDRG1 expression level (Fig. 1A, B) indicating (see
Methods) activation of SGK1. Parallel studies of cells exposed to
Fig. 1. Effects of dexamethasone upon PKA and SGK1. Control cells were main-
tained in hormone-free medium for 24 h whilst dexamethasone-stimulated cells
were exposed to this synthetic glucocorticoid (0.2 mM) for 24 h or 3 h. All cells were
then lysed and aliquots (40 mg) of extracted protein subject to Western analysis.
(A) Typical blots showing the effects of dexamethasone upon the abundance of
Thr346/356/366-phosphorylated (upper panel) and total (lower panel) NDRG1.
(B) Densitometric analysis showing the pooled data (n¼5). (C) Typical Western
blots showing the effects of dexamethasone upon the abundance of Ser133-
phosphorylated (upper panel) and total (lower panel) CREB. (D) Densitometric
analysis showing the pooled data (n¼5). Asterixes denote statistically signiﬁcant
difference from the control values measured in hormone-deprived cells
(nn Po0.02, one- way ANOVA/Bonferroni post-hoc test). All data are mean7S.E.M.
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this synthetic glucocorticoid for 24 h showed that this response
was not sustained and these data thus conﬁrm (see also Inglis et
al., 2009; Watt et al., 2012) that glucocorticoids evoke transient
activation of SGK1 in H441 cells. Dexamethasone (0.2 mM, 3 h or
24 h) had no effect upon the abundance of Ser133-phosphorylated
or total CREB (Fig. 1C, D) and this synthetic hormone thus has no
effect upon PKA. Exposing glucocorticoid-deprived cells to cAMP
agonists (see Methods), on the other hand, increased the abun-
dance of Ser133-phosphorylated CREB without altering the overall
CREB expression level (Fig. 2A, B), and these substances therefore
activate PKA. This response peaked after 20 min and, whilst
there was some subsequent decline, increased activity persisted
for at least 24 h (Fig. 2A, B). Exposure to cAMP agonists also
increased the abundance of the Thr346/356/366-phosphorylated
NDRG1 with no effect upon overall NDRG1 expression (Fig. 2C,
D) indicating activation of SGK1. This response did not become
apparent until 2 h and peaked after 12 h (Fig. 2C, D), and the
cAMP-induced activation of SGK1 therefore occurs more slowly
than the activation of PKA. Brief (3 h) exposure to dexamethasone
thus provides a way of activating SGK1 independently of PKA,
whilst 20 min exposure to cAMP agonists causes selective activa-
tion of PKA. Subsequent experiments therefore explored the effects
of these manoeuvres upon the phosphorylation of Nedd4-2 and the
surface abundance of ENaC subunits.
3.2. Effects of dexamethasone on Nedd4-2
Brief (3 h) exposure to 0.2 mM dexamethasone increased the
abundance of the Ser221-, Ser327- and Thr246-phosphorylated
Nedd4-2 but also increased the overall Nedd4-2 expression level
(Fig. 3). Since overall abundance of Nedd4-2 was assessed by
stripping / re-probing blots that had ﬁrst been probed with a
phospho-peptide speciﬁc antibody (see Methods), we were con-
cerned that this apparent increase may be an artefact caused by the
incomplete removal of these antibodies from the blots. However,
additional experiments in which blots were simply probed with anti-
Nedd4-2 provided virtually identical data and this possibility can
thus be excluded. To quantify the effects of dexamethasone upon the
phosphorylation status of Nedd4-2-Ser221, -Ser327 and -Thr246, the
data from all experiments in which cells were exposed to dexa-
methasone for 3 h (i.e. those shown in Fig. 3, Fig. 4 and Fig. 6) were
further analysed by normalising the increased abundance of each
phosphoprotein to the corresponding increase in total expression.
This analysis showed that the effects of dexamethasone upon the
abundance of Ser221-, Ser327- and Thr246-phosphorylated Nedd4-2
were matched by the increase in overall expression (Ser221:
0.77270.204, Ser327: 0.90970.194, Thr246: 1.10470.193). Activating
SGK by brief exposure to dexamethasone thus increases Nedd4-2
abundance but has no effect upon the relative phosphorylation of
these residues. The SGK inhibitor, GSK650394 (3 h, 10 mM) reduced
the abundance of Ser221-, Ser327- and Thr248-phosphorylated Nedd4-
2 but did not alter the overall expression level. Inhibition of SGK thus
suppresses the basal phosphorylation of these residues. GSK650394
also abolished the effects of dexamethasone (3 h, 0.2 mM) upon the
abundance of phosphorylated and total forms of this protein (Fig. 4).
Prolonged (24 h) exposure to 0.2 mM dexamethasone had no effect
upon the abundance of Ser221-phosphorylated, Ser327-phosphory-
lated or total Nedd4-2 (Fig. 3) and the effects on these residues are
therefore transient. However, increased expression of Thr246-phos-
phorylated Nedd4-2 persisted after 24 h. Since the overall abundance
of Nedd4-2 had returned to its basal value by this time (Fig. 3),
chronic exposure to dexamethasone must cause sustained phosphor-
ylation of Nedd4-2-Thr246. In addition, these data indicate that
phosphorylation of Ser221/Ser327 must be important in the regulation
of Nedd4-2 abundance.
Fig. 2. Activation of PKA and SGK1 by cAMP agonists. Glucocorticoid-deprived cells were exposed (0–24 h) to a cocktail of compounds that promote activation of cAMP-
dependent signalling pathways and 40 mg aliquots of extracted protein then subject to Western analysis. (A) Typical Western blots showing the effects of cAMP agonists upon
the abundance of Ser133-phosphorylated (upper panel) and total (lower panel) CREB. (B) Densitometric analysis showing the pooled data from 5 such experiments.
(C) Western blots showing the effects of cAMP-agonists upon the abundance of Thr346/356/366-phosphorylated (upper panel) and total (lower panel) NDRG1.
(D) Densitometric analysis showing the pooled data (n¼5). Asterixes denote statistically signiﬁcant deviations from control (n, Po0.05; nnn Po0.01, one-way ANOVA/
Bonferroni post-hoc test).
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3.3. Effects of dexamethasone on the surface abundance of ENaC
subunits
Analysis of surface-exposed proteins conﬁrmed (Watt et al.,
2012) that α-, β- and γ-ENaC were present in the membranes of
glucocorticoid-deprived cells (Fig. 5). The antibody against α-ENaC
consistently detected two bands (75 kDa and95 kDa) whilst
β- and γ-ENaC were present as single bands (100 KDa and 70 kDa
respectively). The fact that the antibody against α-ENaC consistently
(see also Watt et al., 2012) identiﬁes two bands is consistent with
the hypothesis that the post-translational processing of α-ENaC
involves cleavage by intracellular and extracellular proteases;
indeed, such proteolytic cleavage is a central part of the mechanism
that allows ENaC to become active (Rossier and Stutts, 2009; Vallet
et al., 1997). Since these proteases act at different sites, the
processing of this channel subunit is known to generate a complex
pattern of polypeptide fragments. The present analyses were under-
taken using antibodies directed against N-terminal residues, and
the apparent pattern of cleavage that we report here is therefore
consistent with that described in earlier studies (Rossier and Stutts,
2009). However, although it is clear that γ-ENaC is also subject to
such proteolytic cleavage (Haerteis et al., 2012; Rossier and Stutts,
2009), we only identiﬁed a single, 70 kDa band in the present study.
Whilst earlier studies of H441 cells, which were undertaken using
the same antibodies, did reveal a second band whose apparent
molecular weight (90 kDa), was consistent with the uncleaved
form of γ-ENaC, the heavier form of this protein was only detected
by analysing proteins that had simply been extracted from intact
cells. Analyses of surface exposed proteins (present study, Watt et
al., 2012), therefore indicate that this ‘full length’ form of γ-ENaC is
not present in the plasma membrane.
Acute (3 h) exposure to dexamethasone increased the surface
abundance all three subunits (Fig. 5) and, whilst the effects on
α-ENaC persisted after 24 h, the surface abundance of β- and
γ-ENaC returned to their basal levels by this time (Fig. 5).
3.4. Effects of cAMP agonists upon Nedd4-2 and ENaC in
glucocorticoid-deprived cells
The control data in Fig. 6 conﬁrm that brief (3 h) exposure to
0.2 mM dexamethasone increases the abundance of Ser221-phos-
phorylated, Ser327-phosphorylated, Thr246-phosphorylated and
total Nedd4-2. Parallel studies of cells acutely (20 min) exposed
to cAMP agonists revealed increased abundance of Ser221-phos-
phorylated and Ser327-phosphorylated Nedd4-2. Whilst these
effects were accompanied by a clear increase in overall Nedd4-2
abundance, the cAMP agonists had no effect upon the abundance
of Thr246-phosphorylated Nedd4-2 (Fig. 6). Experiments in which
dexamethasone-stimulated (0.2 mM, 3 h) cells were exposed to
cAMP agonists for the ﬁnal 20 min of this incubation period
showed that activating PKA has no additional effect upon the
phosphorylation / abundance of Nedd4-2 (Fig. 6). We used a
similar experimental protocol to explore the effects of SGK1 and
/ or PKA upon the surface abundance of α-, β- and γ-ENaC. Brief
(3 h) exposure to 0.2 mM dexamethasone increased the surface
abundance of each subunit (see also Watt et al., 2012) whilst brief
(20 min) exposure to cAMP agonists increased the surface abun-
dance of α-ENaC but had no effect upon the amounts of β- and
γ-ENaC in the membrane (Fig. 7). Analysis of protein from
dexamethasone-stimulated (0.2 mM, 3 h) cells that were also
exposed to cAMP agonists for 20 min showed that PKA activation
had no additional effect upon the surface abundance of α-, β- or
γ-ENaC (Fig. 7). Acutely activating SGK1 and PKA in glucocorticoid-
deprived cells therefore have different effects upon the phosphor-
ylation of Nedd4-2 and the surface expression of ENaC subunits.
3.5. PKA/SGK1 activity in cells chronically (24 h) exposed
to dexamethasone
Applying cAMP agonists (20 min) to cells that had been
exposed to 0.2 mM dexamethasone for 24 h increased the abun-
dance of Ser133-phosphorylated CREB with no effect upon overall
CREB expression (Fig. 8A, B). Since these treatments had no effect
upon the phosphorylation status of NDRG1-Thr346/356/366 (Fig. 8C,
D), these data show that the cAMP agonists selectively activate
PKA. Applying GSK650394 (10 mM, 3 h) to dexamethasone-treated
(24 h) cells suppressed the phosphorylation of NDRG1-Thr346/356/366,
but had no effect upon the cAMP-induced phosphorylation of CREB-
Ser133. As both dexamethasone (24 h) and cAMP agonists (20 min)
did not elevate NDRG1-Thr346/356/366 phosphorylation (Fig. 1) these
ﬁndings establish that GSK650394 inhibits basal SGK1 activity but
does not affect the control of PKA.
3.6. Effects of cAMP agonists upon Nedd4-2 and ENaC in
dexamethasone-treated (24 h) cells
Applying cAMP agonists (20 min) to dexamethasone-treated
(24 h) cells increased the abundance of Ser221- and Ser327-phos-
phorylated Nedd4-2, increased the overall Nedd4-2 expression
level and also increased the abundance of Thr246-phosphorylated
Fig. 3. Effects of dexamethasone upon the phosphorylation/abundance of Nedd4-2.
Nedd4-2 was immunopuriﬁed from glucocorticoid-deprived cells and from cells
exposed to 0.2 mM dexamethasone for 3 h or 24 h. (A) Typical Western blots
showing the effects of dexamethasone stimulation (3 h and 24 h) upon the
abundance of the Ser221-phosphorylated, Ser327-phosphorylated, Thr246-phos-
phorylated and total Nedd4-2. (B–E) Densitometric analysis showing the pooled
data from the entire series of experiments (n¼8). Asterixes denote statistically
signiﬁcant differences from the values measured in hormone-deprived cells
(n Po0.05, one-way ANOVA/Bonferroni post-hoc test). All data are mean7S.E.M.
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Nedd4-2 (Fig. 9A, D). Since the effect on Nedd4-2-Thr246 was not
seen in glucocorticoid-deprived cells, chronic (24 h) exposure to
dexamethasone must allow PKA to phosphorylate this residue.
Applying GSK650394 (10 mM, 3 h) to dexamethasone-treated (24 h)
cells reduced the abundance of the Ser221- and Ser327-phosphory-
lated Nedd4-2 without altering the overall Nedd4-2 expression level
indicating that inhibition of SGK1 suppresses the basal phosphoryla-
tion of these residues. Although there was a reduction in the
abundance of Thr246-phosphorylated Nedd4-2, this effect was not
statistically signiﬁcant (Fig. 9D). In the presence of GSK650394, cAMP
agonists (20 min) increased the abundance of Ser221-phosphorylated,
Ser327-phosphorylated, Thr246-phosphorylated and total Nedd4-2 to
the levels seen in control cells (Fig. 9). The effects of PKA upon the
expression / phosphorylation of Nedd4-2 in dexamethasone-treated
(24 h) cells therefore occur independently of SGK1.
Subsequent experiments used this stimulation protocol to
explore the effects of PKA upon the surface expression of α-,
β- and γ-ENaC in dexamethasone-treated (24 h) cells. All three
ENaC subunits were present in the membranes of control cells
and, whilst the cAMP agonists (20 min) had no effect upon the
surface expression of α-ENaC (Fig. 10A, B, C), they did increase
the amounts of β- (Fig. 10A, D) and γ-ENaC (Fig. 10A, E) in the
membrane. Since these drugs did not alter the surface abundance
of β- and γ-ENaC in glucocorticoid-deprived cells (Fig. 7), the
Fig. 4. Effects of GSK650394 upon the dexamethasone-induced changes to the phosphorylation / abundance of Nedd4-2. Nedd4-2 was immunopuriﬁed from control and
GSK650394-treatred (10 mM, 3 h) cells that were either maintained in hormone-free medium or exposed to 0.2 mM dexamethasone for 3 h. (A) Typical Western blots
showing the effects of dexamethasone and/or GSK650394 upon the cellular abundance of Ser221-phosphorylated, Ser327-phosphorylated, Thr246-phosphorylated and total
Nedd4-2. (B–E) Densitometric analysis showing the pooled results of the entire series of experiments (n¼4). Asterixes denote statistically signiﬁcant effects of
dexamethasone (n Po0.05, nnn Po0.01) whilst daggers († Po0.05, ‡ Po0.01) indicate signiﬁcant effects of GSK650394 (one-way ANOVA / Bonferroni test). All data are
mean7S.E.M.
Fig. 5. Effects of dexamethasone upon the surface abundance of α-, β- and γ-ENaC. Surface-exposed proteins from glucocorticoid-deprived cells and from cells exposed to
0.2 mM dexamethasone for 3 h or 24 h were subject to Western analysis using antibodies against α-, β- or γ-ENaC. (A) Typical Western blots showing the effects of
dexamethasone (3 h and 24 h) upon the surface abundance of these channel subunits. (B) Densitometric analysis showing the results of the entire series of experiments
(n¼7). Asterixes denote statistically signiﬁcant differences from the values measured in hormone-deprived cells (n Po0.05, nnn Po0.001one-way ANOVA / Bonferroni
post-hoc test). All data are mean7S.E.M.
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present data show that chronic (24 h) exposure to dexamethasone
allows PKA to control the surface expression of these subunits.
Exposing dexamethasone-treated cells to GSK650394 reduced the
surface abundance of α- (Fig. 11A, B, C), β- (Fig. 11 A, D) and γ-ENaC
(Fig. 10A, E). However, despite this clear and consistent ﬁnding,
activating PKA under these conditions increased the abundance of
each subunit to the level seen in control cells (Fig. 11). The effects
of cAMP agonists upon the surface expression of ENaC subunits are
therefore independent of SGK1.
3.7. Electrogenic Naþ transport
Electrometric studies of cells grown to conﬂuence on perme-
able supports (see Methods) showed that glucocorticoid-deprived
cells generated 2 mA cm2 of amiloride-sensitive short circuit
current (IAmil). Moreover, although the current recorded from cells
that had been exposed to 0.2 mM dexamethasone for 3 h was
slightly larger, this difference was not statistically signiﬁcant and
we therefore conclude that such brief exposure (3 h) to dexametha-
sone has no discernible effect upon the rate of electrogenic Naþ
transport (Fig. 11 A). Prolonged (24 h) exposure to 0.2 mM dexa-
methasone, on the other hand, caused a clear increase (8 fold) in
the magnitude of IAmil (Fig. 11 A) indicating a clear stimulation of
Naþ transport. Moreover, whilst GSK650394 (10 mM, 3 h) had no
discernible effect upon IAmil in glucocorticoid-deprived cells and in
cells that had been brieﬂy (3 h) exposed to 0.2 mM dexamethasone
(Fig. 11A), this inhibitor of SGK1 consistently reduced the current
recorded from dexamethasone-treated cells to the level seen
glucocortiocoid-deprived cells (Fig. 11A). Chronic exposure to dex-
amethasone therefore induces increased Naþ transport via a
mechanism dependent upon SGK1.
Whilst acute exposure to cAMP agonists enhanced the current
generated by glucocorticoid-deprived cells, this response was very
small (2 mA cm2) and did not reach statistical signiﬁcance; it is
therefore clear that cAMP agonists have no measurable effect upon
the small currents recorded under these conditions. Essentially
Fig. 6. Effects of 0.2 mM dexamethasone (3 h) and / or cAMP agonists (20 min) and upon the phosphorylation / abundance of Nedd4-2. Nedd4-2 was immunopuriﬁed from
glucocorticoid-deprived and dexamethasone-stimulated (0.2 mM, 3 h) cells that had been either maintained under control conditions or exposed to cAMP agonists for the
ﬁnal 20 min of this incubation period. (A) Typical Western blots showing the effects of cAMP and dexamethasone upon the cellular abundance of Ser221-phosphorylated,
Ser327-phosphorylated, Thr246-phosphorylated and total Nedd4-2. (B–E) Densitometric analysis showing the pooled data (n¼3) from the entire series of experiments.
Asterixes denote statistically signiﬁcant effects of dexamethasone (n Po0.05, nnn Po0.01) whilst daggers show signiﬁcant († Po0.05) effects of cAMP agonists (one-way
ANOVA / Bonferroni test). All data are mean7S.E.M.
Fig. 7. Effects of 0.2 mM dexamethasone (3 h) and/or cAMP agonists (20 min) upon the surface abundance of α-, β- and γ-ENaC. Surface-exposed proteins were isolated from
glucocorticoid-deprived and dexamethasone-stimulated cells that were either maintained under control conditions or exposed to the cAMP agonists for the ﬁnal 20 min of
this incubation period. (A) Typical Western blots showing the effects of dexamethasone and/or cAMP agonists upon the surface abundance of α-, β- and γ-ENaC. (B–E)
Densitometric analysis showing the pooled data (mean7S.E.M.) from the entire series of experiments. Asterixes denote statistically signiﬁcant effects of dexamethasone
(n Po0.05, nnn Po0.01) whilst daggers show signiﬁcant († Po0.05) effects of cAMP agonists (one-way ANOVA/Bonferroni post-hoc test). All data are mean7S.E.M.
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identical data were recorded from cells that had been exposed to
dexamethasone for only 3 h, and such brief exposure to this
synthetic glucocorticoid therefore has no effect upon this response
to cAMP agonists. However, when applied to cells that had been
exposed to dexamethasone for 24 h, the cAMP agonists consis-
tently increased the magnitude of IAmil (ΔIAmil5 mA cm−2, Fig. 11B)
indicating a clear stimulation of Naþ transport. It is now clear that
chronic exposure to dexamethasone enhances the effects of cAMP
upon electrogenic Naþ transport. GSK650394 (10 mM, 3 h) had no
effect upon the small responses to cAMP agonists seen in
glucocorticoid-deprived cells and in cells exposed to dexametha-
sone for 3 h, and also failed to modify the much larger responses
seen in cells exposed to dexamethasone for 24 h (Fig. 11B).
4. Discussion
4.1. Experimentally-induced activation of SGK1 and PKA
Dexamethasone caused transient activation of SGK1 (see also
Inglis et al., 2009; Watt et al., 2012) but not PKA whilst cAMP
agonists activated both kinases. The additional effect of cAMP
accords with earlier data which suggest that activating PKA
increases cellular SGK1 activity by evoking SGK1 gene expression
and by phosphorylating SGK1-Thr389. It has therefore been sug-
gested that the PKA/cAMP-coupled agonists might stimulate Naþ
transport via a mechanism dependent upon SGK1 (Gonzalez-
Robayna et al., 2000; Perrotti et al., 2001; Thomas et al., 2004;
Vasquez et al., 2008). However, not all data support this view (see
for example Inglis et al., 2009; Mansley and Wilson, 2010; Snyder
et al., 2004a) and we now show the cAMP-induced activation of
PKA is rapid whilst the increase in SGK1 activity involves a latency
of 2 h. In contrast, functional studies clearly show that PKA-
coupled agonists stimulate Naþ transport within 5–10 min (Clunes
et al., 2004; Lazrak and Matalon, 2003; Mansley and Wilson, 2010;
Morris and Schafer, 2002; Ramminger et al., 2004; Thomas et al.,
2004). Whilst PKA-induced activation of SGK1 (Gonzalez-Robayna
et al., 2000; Perrotti et al., 2001; Thomas et al., 2004; Vasquez et
al., 2008) may contribute to the responses to maintained stimula-
tion, it cannot explain the rapid responses seen in human airway
epithelia (Clunes et al., 2004; Lazrak and Matalon, 2003;
Ramminger et al., 2004; Thomas et al., 2004).
4.2. Changes to the overall abundance of Nedd4-2
Selectively activating SGK1 by brief (3 h) exposure to dexa-
methasone increased the abundance of Ser221-, Ser327- and
Thr246-phosphorylated Nedd4-2 indicating that these residues are
SGK1 substrates (Debonneville et al., 2001; Snyder et al., 2004a;
Snyder et al., 2002). However, these effects were accompanied by
clear increases in overall Nedd4-2 abundance and, since the
magnitudes of the two responses were similar, activating SGK1
did not change the relative phosphorylation status of Nedd4-2-
Ser221, -Ser327 or -Thr246. It is important to stress that this does not
imply that phosphorylation of these residues does not take place.
Indeed, phosphorylation must occur if the phosphorylation status of
each residue is to be maintained despite an increase in overall
abundance. In this context it is relevant that studies of Xenopus
Nedd4-2 show that phosphorylation of a residue equivalent to
human Nedd4-2-Ser327 blocks the degradation of this protein
(Chandran et al., 2011). Moreover, since the degradation of
Nedd4-2 is normally rapid (Bruce et al., 2008), it has been suggested
that the phosphorylation of Nedd4-2 at Ser327 might increase the
stability of the protein and thus increase its abundance (Chandran
et al., 2011). Whilst the present data are consistent with this
hypothesis, we cannot exclude the possible that other mechanisms
may underlie the observed changes to the overall abundance of
Nedd4-2. For example, the present data would also be consistent
with a model in which dexamethasone promoted the de novo
synthesis of Nedd4-2 protein which was then phosphorylated by
SGK1. More detailed studies using fully quantitative methods are
therefore needed to establish the physiological basis of this effect.
4.3. Acute activation of PKA or SGK1 has different effects upon
Nedd4-2 and ENaC
Whilst acute (3 h) activation of SGK1 caused phosphorylation
of Nedd4-2-Ser221, -Ser327 and -Thr246, activating PKA in
glucocorticoid-deprived cells caused phosphorylation of Nedd4-
Ser221 and Nedd4-Ser327 but not Nedd4-2-Thr246. Whilst these
ﬁndings suggest that Nedd-4-2-Thr246 is not be phosphorylated by
PKA, we cannot formally establish this mechanism since similar
data would be obtained if the cAMP agonists were able to promote
the dephosphoryation of this residue. However, it is relevant our
ﬁndings do accord with data derived from heterologously-
expressed Nedd4-2 which do show that Thr246 is a substrate for
SGK1 but not PKA (Debonneville et al., 2001; Snyder et al., 2002,
2004a). Moreover, whilst acute activation of SGK1 increased the
Fig. 8. Effects of GSK650394 and/or cAMP agonists upon PKA and SGK1 in cells
chronically (24 h) exposed to 0.2 mM dexamethasone. Dexamethasone-treated
(0.2 mM, 24 h) cells (n¼3) were exposed to cAMP agonists 20 min under standard
conditions and in the presence of GSK650394 (10 mM, 3 h) and aliquots (40 mg) of
extracted protein then subject to Western analysis. (A) Typical Western blots
showing the effects of GSK650394 and/or cAMP agonists upon the abundance of
Ser133-phosphorylated and total CREB. (B) Densitometric analysis showing pooled
data (n¼3) from the entire series of experiments. (C) Typical Western blots
showing the effects of GSK650394 and/or cAMP agonists upon the abundance of
Thr346/356/366-phosphorylated (upper panels) and total NDRG1 (lower panels).
(D) Densitometric analysis showing pooled data (n¼3) from the entire series of
experiments. Asterixes denote statistically signiﬁcant effects of cAMP agonists
(nnn Po0.01) whilst daggers (†, Po0.05) denote statistically signiﬁcant effects of
GSK650394 (one-way ANOVA / Bonferroni post-hoc test). All data are mean7S.E.M.
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surface abundance of α-, β- and γ-ENaC, activating PKA increased
the abundance of α-ENaC with no effect upon β- and γ-ENaC.
Activating PKA in glucocorticoid-deprived cells therefore fails
to induce a coordinated increase in the surface expression of
α-, β- and γ-ENaC, and this is consistent with the idea that control
over the surface abundance of ENaC subunits requires the phos-
phorylation of Nedd4-2 at both Ser327 and Thr246 (Chandran et al.,
2011; Snyder et al., 2004a).
4.4. Acute and chronic effects of dexamethasone
As anticipated (Althaus et al., 2010; Ramminger et al., 2004),
prolonged (24 h) exposure to dexamethasone consistently induced
a Naþ absorbing phenotype. However, whilst the effects of dexa-
methasone upon SGK1, Nedd4-2 and the surface abundance of
ENaC all peaked after 3 h (present study, Inglis et al., 2009; Watt
et al., 2012), such brief exposure to dexamethasone had no
discernible effect upon electrogenic Naþ transport. Moreover,
whilst chronic exposure to dexamethasone consistently evoked
Naþ transport via an SGK1-dependent mechanism, this stimulus
did not cause persistent activation of SGK1 (present study, Inglis et
al., 2009; Watt et al., 2012). Furthermore, whilst chronic exposure
to dexamethasone caused persistent phosphorylation of Nedd4-2-
Thr246, the abundance of Ser221-phosphorylated, Ser327-phos-
phorylated and total Nedd4-2 had all fallen to the levels seen in
glucocorticoid-deprived cells after 24 h exposure to this synthetic
hormone. In addition, although prolonged stimulation increased
the surface abundance of α-ENaC it had no effect upon β-ENaC or
Fig. 9. Effect of cAMP agonists and / or GSK650394 upon the phosphorylation /abundance of Nedd4-2 in dexamethasone-treated (0.2 mM, 24 h) cells. Proteins
immunopuriﬁed from dexamethasone-treated (0.2 mM, 24 h) cells either maintained under standard conditions or exposed to cAMP agonists for 20 min (n¼3). Experiments
were undertaken using both control and GSK650394-treated (10 mM, 3 h) cells. (A) Typical Western blots showing the effects of cAMP and / or GSK650394 upon the cellular
abundance of Ser221-phosphorylated, Ser327-phosphorylated, Thr246-phosphorylated and total Nedd4-2. (B–E) Densitometric analysis showing the pooled data (n¼3) from
the entire series of experiments. Asterixes denote statistically signiﬁcant effects of cAMP agonists (nnn Po0.01) whilst daggers (†, Po0.05) denote statistically signiﬁcant
effects of GSK650394 (one-way ANOVA/Bonferroni post-hoc test). All data are mean7S.E.M.
Fig. 10. Effect of cAMP agonists and / or GSK650394 upon the surface abundance of α-, β- and γ-ENaC in dexamethasone-treated (0.2 mM, 24 h) cells. Surface-exposed
proteins were isolated from dexamethasone-treated (0.2 mM, 24 h) cells that had been maintained under standard conditions or exposed to cAMP agonists for 20 min.
Experiments were undertaken both under control conditions and in the presence of GSK650394 (10 mM, 3 h). (A) Typical Western blots showing the effects of cAMP and/or
GSK650394 upon the surface abundance of α-, β- and γ-ENaC. (B–E) Densitometric analysis showing the pooled data (n¼3) from the entire series of experiments. Asterixes
denote statistically signiﬁcant effects of cAMP agonists (nnn Po0.01) whilst daggers (†, Po0.05) denote statistically signiﬁcant effects of GSK650394 (one-way ANOVA /
Bonferroni post-hoc test). All data are mean7S.E.M.
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γ-ENaC (see also Watt et al., 2012). This selective increase in the
surface abundance of α-ENaC cannot explain the increased Naþ
transport since acute exposure to cAMP agonists had an essentially
identical effect upon the surface abundance of ENaC subunits and
yet caused only a very small increase in the rate of Naþ transport
(see above). The sustained absorption of Naþ that is character-
istically seen in dexamethasone-treated H441 cells (Althaus et al.,
2010; Inglis et al., 2009; Ramminger et al., 2004) therefore occurs
independently of maintained phosphorylation of Nedd4-2-Ser221
and Nedd4-2Ser327, and does not involve a coordinated increase in
the surface abundance of α-, β- and γ-ENaC. Nevertheless,
GSK650394-mediated inhibition of SGK1 suppressed the phos-
phorylation of Nedd4-2-Ser221 and -Ser327 and also reduced the
surface abundance of α-ENaC, and these ﬁndings show that SGK1
activity is needed to maintain α-ENaC in the membranes. This, in
turn, suggests that α-ENaC might contribute to the increased Naþ
transport.
Whilst our data show that signalling via SGK1 – Nedd4-2
allows control over the surface abundance of ENaC subunits
(Boase et al., 2011; Debonneville et al., 2001; Flores et al., 2003,
2005; Kimura et al., 2011; Morris and Schafer, 2002; Snyder et al.,
2002, 2004a, 2004b), they also indicate that signalling via this
pathway cannot explain how prolonged exposure to glucocorti-
coids is able to induce a Naþ absorbing phenotype. However,
earlier studies of heterologously expressed Nedd4-2 suggest that
Thr246 is of central importance to the control over the surface
abundance of ENaC subunits (Chandran et al., 2011; Snyder et al.,
2004a) and it is therefore interesting that prolonged exposure to
dexamethasone did cause sustained phosphorylation of this resi-
due. Moreover, that fact that this effect persisted in the presence of
GSK650394, indicates that this response is maintained indepen-
dently of SGK1.
4.5. Chronic exposure to dexamethasone enhances the effects of
activating PKA
Acutely activating PKA in dexamethasone-treated cells pro-
moted phosphorylation of all three residues within Nedd4-2,
increased the surface abundance of α-, β- and γ-ENaC, and caused
an unambiguous stimulation of Naþ transport. Since these
responses differ from those seen in glucocorticoid-deprived cells,
our data show that, as well as inducing a Naþ absorbing pheno-
type, glucocorticoids allow cAMP agonists to control Naþ trans-
port via the PKA – Nedd4-2 – ENaC pathway. This situation
resembles that seen in the lungs of foetal lambs (Barker et al.,
1990; Olver et al., 1986; Walters et al., 1990) and in primary
cultures of foetal rat distal lung epithelial cells (Ramminger et al.,
2002) where the cAMP-dependent control of Naþ transport
requires prior exposure to glucocorticoid / thyroid hormones.
Moreover, whilst the direct effects of dexamethasone upon Naþ
transport were abolished by GSK650394, cAMP agonists could still
activate the PKA – Nedd4-2 – ENaC pathway in GSK650394-
treated cells. Whilst these data accord with earlier observations
which suggest that cAMP agonists control Naþ-transport via a
mechanism that is independent of SGK1 (Inglis et al., 2009;
Mansley and Wilson, 2010; Snyder et al., 2004a), they also show
that SGK1 cannot mediate the permissive effects of dexametha-
sone which we now report.
4.6. Conclusions and signiﬁcance of present ﬁndings
The present studies of endogenously expressed proteins show
that dexamethasone activates SGK1, induces phosphorylation of
Nedd4-2 and increases the surface abundance of ENaC subunits.
However, these effects did not coincide with the stimulation of
Naþ transport and it is therefore clear that signalling via SGK1 –
Nedd4-2 – ENaC cannot account for the enhanced Naþ transport
seen in glucocorticoid-stimulated cells. Other factors, such as
effects on the Naþ pump, Kþ channels and other components of
the ENaC channel complex (Barnes, 2011), must therefore be
important. Dexamethasone-induced Naþ transport was, however,
dependent upon SGK1 indicating that this kinase must play a
central role. It is therefore interesting that SGK1 appears to
activate ENaC by directly phosphorylating residues within α-ENaC
itself (Diakov and Korbmacher, 2004). However, the most impor-
tant ﬁnding to emerge from the present study was that prolonged
exposure to dexamethasone allowed cAMP agonists to evoke
phosphorylation of Nedd4-2 at Thr246. Earlier studies had indi-
cated that Nedd4-2-Thr246 was of critical important to the control
of ENaC abundance (Chandran et al., 2011; Snyder et al., 2004a),
and it is therefore interesting that dexamethasone also allowed
cAMP agonists to induce coordinated increases in the surface
abundance of α-, β- and γ-ENaC and to stimulate Naþ absorption.
As well as inducing a stable, Naþ absorbing phenotype, glucocor-
ticoids therefore facilitate signalling via the PKA – Nedd4-2 – ENaC
pathway and thus allow cAMP agonists to exert acute control over
the rate of Naþ absorption.
Fig. 11. Effects of cAMP agonists / GSK650394 on electrogenic Naþ absorption in glucocorticoid-deprived and dexamethasone-treated cells. (A) Cells grown to conﬂuence on
permeable supports were either deprived of glucocorticoids for 24 h, or exposed to 0.2 mM dexamethasone for 3 h or 24 h. Control/GSK650394-treated (10 mM, 3 h) cells
were then mounted in Ussing chambers and amiloride-sensitive short circuit current (IAmil) quantiﬁed as an indicator of the electrogenic Naþ transport rate. (B) Cyclic AMP
agonist-induced increases in IAmil above the levels quantiﬁed in parallel studies of unstimulated cells that were age matched, at identical passage number and had been
maintained in Ussing chambers for identical time periods. Presented values of P denote statistically signiﬁcant effects of GSK650394 whilst asterixes denote signiﬁcant
effects of dexamethasone (Po0.05, one-way ANOVA/Bonferroni post-hoc test). All data are mean7S.E.M.
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